Theralase Technologies Inc. (TSXV:TLT)
Canada flag Canada · Delayed Price · Currency is CAD
0.1900
-0.0050 (-2.56%)
Nov 3, 2026, 11:11 AM EST

Theralase Technologies Ratios and Metrics

Millions CAD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
594466406977
Market Cap Growth
20.78%-33.43%64.23%-42.29%-9.56%97.37%
Enterprise Value
544466406772
Last Close Price
0.200.170.270.170.320.38

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
39.0031.5031.5031.5031.5031.50
PS Ratio
75.4553.5463.5437.3560.8598.13
PB Ratio
8.8524.5931.7620.9822.4015.11
P/TBV Ratio
8.8524.5931.7620.9822.4015.11

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
69.0853.8363.5337.5259.1391.82

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.020.260.140.200.150.01
Net Debt / Equity Ratio
-0.750.160.010.18-0.33-0.72
Net Debt / EBITDA Ratio
1.40-0.07-0.01-0.080.210.85
Net Debt / FCF Ratio
1.52-0.08-0.01-0.080.200.89
Asset Turnover
0.140.240.320.290.230.10
Inventory Turnover
0.560.590.800.890.970.92
Quick Ratio
4.890.850.990.602.864.56
Current Ratio
5.481.251.611.393.675.71
Return on Equity (ROE)
-93.40%-214.33%-214.26%-182.91%-128.27%-61.98%
Return on Assets (ROA)
-42.70%-77.42%-82.17%-77.21%-64.71%-35.56%
Return on Capital Employed (ROCE)
-55.30%-223.10%-189.70%-208.90%-150.40%-89.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-7.49%-9.43%-6.48%-11.43%-7.56%-5.76%
FCF Yield
-5.56%-7.63%-5.13%-10.28%-7.47%-5.39%
Buyback Yield / Dilution
-7.23%-5.44%-9.14%-5.79%-1.79%-